Research and Markets (http://www.researchandmarkets.com/research/8l4tsp/retinitis) has announced the addition of the "Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013" report to their offering.

'Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Retinitis Pigmentosa (Retinitis).

Scope

  • A snapshot of the global therapeutic scenario for Retinitis Pigmentosa (Retinitis).
  • A review of the Retinitis Pigmentosa (Retinitis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Retinitis Pigmentosa (Retinitis) pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Companies Involved in Therapeutics Development

  • QLT Inc.
  • Sanofi
  • Sangamo BioSciences, Inc.
  • Sun Pharmaceutical Industries Limited
  • BioDiem Ltd
  • ReGenX Biosciences, LLC
  • ReNeuron Group plc
  • R-Tech Ueno, Ltd.
  • Neurotech Pharmaceuticals, Inc.
  • Orphagen Pharmaceuticals, Inc.
  • Grupo Ferrer Internacional, S.A.
  • Stemedica Cell Technologies, Inc.
  • Asklepios BioPharmaceutical, Inc.
  • to-BBB technologies BV
  • Dompe Farmaceutici S.p.A.
  • DNAVEC Corporation
  • Bikam Pharmaceuticals, Inc.
  • Mimetogen Pharmaceuticals Inc.
  • Genable Technologies Limited
  • Amarantus Bioscience Holdings, Inc.
  • ProRetina Therapeutics, S.L
  • RetroSense Therapeutics, LLC
  • GenSight Biologics

For more information visit http://www.researchandmarkets.com/research/8l4tsp/retinitis

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals